Here is a the result from our first AI based newsletter regarding rheumatoid arthritis.
Many medical device manufacturers have found themselves caught in a trap where they have received NUB status 1 and/or 4 but the hospitals were rejected during the negotiation with the insurance companies.
Based on the experience of the hundreds of projects we have delivered, we have developed a new solution to provide a comprehensive overview of your reimbursement situation including information (op
We are happy to announce that new member of Synergus team is Dr. Huseyin Aytug. Dr. Huseyin has B.A in Economics with distinction from Marmara University in Istanbul, Turkey, M.A (2010) and Ph.D. (2013) both in International Economics from University of California-Santa Cruz, US.